Introduction {#sec1}
============

Natural products have been an exceptional source of small molecules for drug discovery. In the human history, plants and animal-derived natural products have found direct applications in almost all traditional medical preparations. In modern drug discovery, they are continuously entering clinical trials and also have provided leads for new drugs.^[@ref1]^ However, a unique problem associated with the development of natural product-based drugs are the difficulty to access sufficient quantities of compounds required for comprehensive biochemical investigations and marketing purposes. This is because of the isolation of the natural product in limited quantities and also the stereochemical complexity of their chemical structures that make their synthesis in quantitative amounts challenging.^[@ref2]^ Hence, there is a need to develop short and high-yielding practical synthetic routes, either with existing or through the development of new chemical technologies.^[@ref2]^ In our journey with the above perspective and inspired by interesting structural features and anticancer activities of yaoshanenolides A (**1**) and B (**2**), we have developed the shortest route for their synthesis.

Recently, in the year 2012, Lin and Shi's group isolated two novel tricyclic spirolactones yaoshanenolides A (**1**) and B (**2**) possessing unprecedented 5′*H*-spiro-\[bicyclo\[2.2.2\]-oct\[2\]ene-7,2′-furan\]-5′-one scaffold and homologous alkyl side chain from the stem bark of *Machilus yaoshansis*.^[@ref3]^ Several plants of this genus (*Lauraceae* family) have been known to produce arrays of secondary metabolites with significant biological profiles and have been extensively used as traditional folk medicine in China.^[@ref4]^ In addition to this ethnic usage of the plant, compounds **1** and **2** showed significant cytotoxic activities against several human cancer cell lines (A549) with IC~50~ values of 5.1--6.6 μM.^[@ref3]^ The relative stereochemistry of yaoshanenolides A and B (**8** and **9**, proposed structures) was tentatively established based on 2D NMR analysis, and the (*S*) absolute stereochemistry of the secondary hydroxyl functionality was deduced using the bulkiness rule for the Rh~2~(OCOCF~3~)~4~-induced circular dichroism analysis. In addition, they proposed a biosynthetic pathway, comprising the Diels--Alder reaction of suitable obtusilactones (**3--6**) and unnatural α-(+)-phellandrene (**7**) to afford both natural products (**8** and **9**), among which the structure of the compound **9** was revised recently (vide infra) ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}).^[@ref3]^

![Revised and Proposed Structures and the Biosynthetic Pathway of Yaoshanenolides A and B](ao-2018-00701b_0003){#sch1}

Soon after the isolation, Singh research group accomplished the tricyclic spirolactone core of yaoshanenolides in a 10-step linear synthesis, using their in-house protocol of cycloaddition of reactive spiroepoxycylohexa-2,4-dienone with ethyl acrylate.^[@ref5]^ In 2016, Stratakis's group reported a highly expedient first total synthesis and structural revision of (+)-yaoshanenolide B (**2**) via the Diels--Alder reaction between *R*-(−)-α-phellandrene and 5-methylene-2(5*H*)-furanone derivative in 8 steps and 6.2% overall yield.^[@ref6]^

Results and Discussion {#sec2}
======================

As described in the retrosynthetic analysis in [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}, we have designed two unified approaches to access both natural products **1** and **2**. In the first approach, we envisioned that **1** and **2** could be accessed from tricyclic spirolactone **10** via Morita--Baylis--Hillman coupling with a suitable commercially available aldehyde. The lactone **10** could be readily prepared through the Diels--Alder reaction between known 5-methylene-2(5*H*)-furanone (protoanemonin) (**11**) and *R*-(−)-α-phellandrene (**12**). The oxidation of 2-methylfuran (**13**) followed by dehydration could deliver the desired dienophile **11**. In contrast, the second approach uses the fully functionalized 5-methylene-2(5*H*)-furanone derivative (±)-**14** as the dienophile, which would be obtained from commercially available γ-butyrolactone (**15**) ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}).

![Retrosynthetic Analysis of Two Unified Strategies for Yaoshanenolides A (**1**) and B (**2**)](ao-2018-00701b_0004){#sch2}

Our first approach to (+)-yaoshanenolide B (**2**) is outlined in [Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}. Oxidation of 2-methylfuran (**13**) using Pinnick's conditions (NaClO~2~ and NaH~2~PO~4~) gave 5-hydroxy-5-methylfuran-2(5*H*)-one (**16**), which was immediately subjected to P~2~O~5~-mediated dehydration reaction to furnish 5-methylene-2(5*H*)-furanone (**11**) in 71% yield (for two steps).^[@ref7]^ Next, the Diels--Alder cycloaddition between dienophile **11** and natural *R*-(−)-α-phellandrene (**12**) under known reaction conditions^[@ref8]^ of toluene, 110 °C for 12 h, afforded tricyclic spirolactone adducts **10a** (endo, less polar) and **10b** (exo, more polar) together with negligible quantities of their regio-isomers. Even though this transformation was reported earlier, no clear analytical data were available to establish the structures of **10a** and **10b**.^[@ref8]^ Hence, we carried out a systematic 2D NMR (COSY, HMBC, HSQC, and NOESY) analysis of these two compounds. The HSQC data established all ^1^*J*~^1^H--^13^C~ connectivities; the remaining skeletal connectivities were confirmed particularly by COSY and HMBC data ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). The complete stereochemistry of **10a** and **10b** was established by the examination of their NOESY data and the known absolute configuration of **12**. In the case of adduct **10a**, strong nuclear Overhauser effect (NOE) correlations of H-6 with H-1/H-9/H~3~-10/H~3~-12/H-3′ and H-1 with H-3′/H-6 confirmed the endo- and 1*R*,2*R*,4*R*,7*R* stereochemistry. In the case of adduct **10b**, correlations of H-5 with H-4/H~3~-12/H-9/H~3~-11, H-1 with H-7, and H-3′ with H-8 confirmed its exo- and 1*S*,2*R*,4*R*,8*R* stereochemistry ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).[a](#fn1){ref-type="fn"}

![Key COSY (dark bonds) and HMBC (red arrows) correlations (A,B); key NOE correlations (blue arrows, C,D) in **10a** and **10b**.](ao-2018-00701b_0001){#fig1}

![Unsuccessful First Synthetic Approach to (+)-Yaoshanenolide B (**2**)](ao-2018-00701b_0005){#sch3}

After establishing the structures of both adducts **10a** and **10b**, we turned our attention to executing the final Morita--Baylis--Hillman^[@ref9]^ coupling between endo-adduct **10a** and 1-dodecanal (**17**), which was expected to furnish the desired natural product **2** and its C1″-epimer **2a**. Unfortunately, this coupling reaction using several reported procedures (DABCO; TMEDA, MgI~2~; TEA; DMAP; LiClO~4~, DABCO; imidazole; TiCl~4~; or *n*-Bu~2~BOTf)^[@cit10a]−[@cit10i]^ proved to be insurmountable, and in all cases, the starting adduct **10a** remained unreactive and fully recovered ([Table S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b00701/suppl_file/ao8b00701_si_001.pdf)).[a](#fn1){ref-type="fn"} In addition to this, we planned a roundabout process ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}), where the α,β-unsaturated double bond in lactone segment of **10a** was selectively reduced using Mg--MeOH^[@ref11]^ to give the corresponding tricyclic spirolactone, which was subsequently converted into diastereomeric α-phenylselanyl derivative (**18** and **18a**). Then, the generation of lithium enolate of lactone **18** or **18a** using LDA followed by its addition to the aldehyde **17** was unsuccessful and led to the decomposition. Thus, we have abandoned this strategy and proceeded to the second approach ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}).

In our second approach, first, the total synthesis of (+)-yaoshanenolide B (**2**) was planned, which would allow us to compare and confirm the stereochemical outcome with respect to its proposed^[@ref3]^ and revised^[@ref6]^ structures. Thus, racemic dienophile **14a** was prepared from γ-butyrolactone (**15**) in three steps (by a modification of Queneau's procedure^[@ref13]^). LiHMDS- and TMSCl-mediated phenylselenation of **15** gave the α-phenylselanyl intermediate **19** in 79% yield. The addition of lithium enolate of **19** onto the 1-dodecanal (**17**), followed by immediate oxidative elimination of phenyl selenenic acid using H~2~O~2~, delivered the hydroxy-alkyl tethered α-β-unsaturated lactone **21** in 81% yield.^[@ref12]^ Then, exocyclic olefination of **21** using LDA and Eschenmoser's salt gave the desired dienophile **14a** in 52% yield.^[@ref13]^ On the basis of the earlier report,^[@ref3]^ the \[4 + 2\]-cycloaddition reaction between fully functionalized dienophile **14a** and *R*-(−)-α-phellandrene (**12**) was expected to be challenging because of the labile hydroxyl group in **14a** ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}).

![Total Synthesis of (+)-Yaoshanenolides B (**2**), Its C1″-Epimer (**2a**), and Exo-Isomers (**2′** and **2a′**)](ao-2018-00701b_0006){#sch4}

Hence, we were inquisitive to verify the feasibility of this transformation. To our delight, this key cycloaddition between **14a** and **12** in toluene at 110 °C for 20 h furnished (+)-yaoshanenolide-B (**2**, more polar) and its C1″-epimer **2a** (less polar) in 1:1 ratio with high facial and regio-selectivity in a good yield of 75%. To our surprise, respective exo-isomers (**2′** and **2a′**) were detected in small amounts (in ∼93:7 endo/exo ratio), and we did not observe any other products among a total of 16 isomers (from two diastereotopic faces of the (±)-**14** (dienophile) and the unsymmetrical diene (**12**) each) possible in this reaction ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}). Utilizing the same strategy (+)-yaoshanenolide A (**1**, more polar) and its C1″-epimer **1a** (less polar) in 1:1 ratio was accomplished for the first time using 1-tetradecanal (**20**) in step 2 (**19** → **22** → **14b** → **1** and **1a**; [Schemes [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"} and [5](#sch5){ref-type="scheme"}). Even after much effort, we were unable to designate exo isomers of yaoshanenolides A and B (**2′** and **2a′** and **1′** and **1a′**) through NMR analyses, which could be due to their presence in lower quantities. Hence, we have prepared authentic samples using Stratakis's protocol^[@ref6]^ of Diels--Alder reaction between acetate-protected dienophile **14a′** and *R*-(−)-α-phellandrene (**12**) followed by acetate deprotection and assigned endo/exo ratios based on reported results^[@ref6]^ and analogy (through careful ^1^H NMR analyses, see the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.8b00701/suppl_file/ao8b00701_si_001.pdf) for details).

![Total Synthesis of (+)-Yaoshanenolides A (**1**), Its C1″-Epimer (**1a**), and Exo-Isomers (**1′** and **1a′**)](ao-2018-00701b_0007){#sch5}

Even though compounds **1**, **1a**, **2**, and **2a** were clearly separable by silica gel column chromatography and the specific rotation data of **1**, **2**, and **2a** are very close to reported values, we were unable to completely assign their structures at this stage because of their indistinguishable ^1^H and ^13^C NMR spectral data. Hence, we established structures through 2D NMR analysis (COSY, HSQC, and HMBC).[a](#fn1){ref-type="fn"} The NOESY analysis of **1**, **2**, **1a**, and **2a** showed a similar correlation of H-3′ with H-1/H-6, H-1 with H-6/H-7/H-9/H~3~-10, and H-6 with H~3~-12/H-9/H~3~-10, which confirmed their endo-stereochemistry. In addition, the absolute stereochemistry of the secondary hydroxyl functionality was assigned through the synthesis of corresponding MPA esters using (*S*)-MPA and compared relative proton chemical shifts with that of reported data.^[@ref6]^ On the basis of the above analysis and known absolute stereochemistry of **12**, complete structures of both natural products yaoshanenolide A ((1*R*,2*S*,4*R*,7*R*,1″*S*)-**1**) and B ((1*R*,2*S*,4*R*,7*R*,1″*S*)-**2**) and their C1″-epimers ((1*R*,2*S*,4*R*,7*R*,1″*R*)-**1a** and (1*R*,2*S*,4*R*,7*R*,1″*R*)-**2a**) were established ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"} and [Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}).

![Key NOE correlations in **1**, **2**, **1a**, and **2a**.](ao-2018-00701b_0002){#fig2}

![Synthesis of MPA Esters of (+)-Yaoshanenolides A (**1**) and B (**2**) and Their C1″-Epimers (**1a** and **2a**)](ao-2018-00701b_0008){#sch6}

To understand and rationalize this remarkable face and regio-selectivity, we have drawn four most prominent transition states using the (*S*)-enantiomer of the dienophile **14a** that is approaching the less hindered face of the (*R*)-α-phellandrene (**12**) among a total of eight possible transition states ([Scheme [7](#sch7){ref-type="scheme"}](#sch7){ref-type="scheme"}). The Re or Si face of the exocyclic double bond of the dienophile (*S*)-**14a** approaching the less hindered face of the diene (**12**) in an endo fashion provides two transition states (**TS-A** and **TS-B**); in a similar fashion providing two more exo-transition states is also possible (**TS-C** and **TS-D**). In addition to these four transition states, two exo and two endo transition states can arise through the approach of the dienophile (*S*)-**14a** toward the more hindered face of the diene **12**, these transition states could be highly energetic due to the unfavorable severe steric interactions between isopropyl group of the diene **12** and dienophile (*S*)-**14a**; hence, we have excluded those transition states in this discussion. In the case of **TS-A**, the less hindered face of the (*R*)-α-phellandrene (**12**) approaches the Si face of the double bond of the dienophile (*S*)-**14a** in an endo fashion, which leads to the formation of corresponding natural product (+)-yaoshanenolide B (**2**). Another possible endo transition state (**TS-B**) involving the Re face of the double bond of the dienophile (*S*)-**14a** develops significant steric interactions between the vinylic methyl group of diene **12** and the hydroxyl functionality of the dienophile (*S*)-**14a** ([Scheme [7](#sch7){ref-type="scheme"}](#sch7){ref-type="scheme"}).

![Possible Transition States in the Diels--Alder Reaction of (*S*)-**14a** and the Less Hindered Face of (*R*)-α-Phellandrene (**12**)](ao-2018-00701b_0009){#sch7}

In other possible two exo approaches with any facial orientation of the dienophile (*S*)-**14a** (either Si or Re face), molecular models revealed that no significant steric interactions develop between the isopropyl group of the (*R*)-α-phellandrene (**12**) and dienophile (*S*)-**14a**; this observation is in contrast with that of Stratakis's report^[@ref6]^ ([Scheme [7](#sch7){ref-type="scheme"}](#sch7){ref-type="scheme"}). In spite of negligible steric interactions in the case of exo transition states (**TS-C** and **TS-D**), **TS-C** gave corresponding exo adduct **2′** as a minor product, whereas **TS-D** failed to furnish the corresponding exo adducts **2c**. Among two possible endo adducts **2** and **2b** via **TS-A** and **TS-B**, respectively, adduct **2** only formed via **TS-A** and **TS-B** failed to deliver the adduct **2b** because of steric interactions ([Scheme [7](#sch7){ref-type="scheme"}](#sch7){ref-type="scheme"}).

To further understand the observed endo selectivity, we compared the stereochemical outcome of the Diels--Alder reaction of dienophiles **11**, **14a′**, and **14a** with diene **12** through **TS-A** and **TS-C** ([Scheme [8](#sch8){ref-type="scheme"}](#sch8){ref-type="scheme"}). The unsubstituted dienophile **11** furnished almost equal amounts of endo and exo adducts **10a** and **10b** (eq 1), whereas the dienophile **14a′** (possessing acetate derived alkyl chain), which was used in Stratakis's work, gave endo and exo adducts in 3:1 ratio (eq 2). In contrast to these results, dienophile **14a** possessing free hydroxy tethered alkyl chain furnished the endo (**2**) and exo (**2′**) adducts in ∼93:7 ratio (eq 3). On the basis of these observations, we assume that the endo-rule is governing the stereochemical outcome and also there is an inherent role of the side chain with the free hydroxyl group in stabilizing the endo transition state (**TS-A**). However, the establishment of the precise reaction pathway requires further mechanistic investigations.

![Comparison of the Endo Selectivity in Diels--Alder Reaction of (*R*)-α-Phellandrene (**12**) and Differently Substituted Dienophiles (**11**, **14a′**, **14a**) through **TS-A** (Endo, Si-Face)](ao-2018-00701b_0010){#sch8}

Conclusion {#sec3}
==========

In summary, (+)-yaoshanenolides A and B were prepared in four linear steps from commercially available and affordable starting materials with remarkable face- and endo-selectivity, and an overall yield of 11 and 13%, a marked improvement over existing synthesis. The absolute stereochemistry of (+)-yaoshanenolides A and B and their epimers and the Diels--Alder product of protoanemonin and *R*-(−)-α-phellandrene were established by extensive NMR analysis. This highly concise and efficient route enables the synthesis of yaoshanenolides and their analogs in good quantities and provides a means to further investigate the biological profile. Our studies in this direction are in progress and will be published in due course.

Experimental Section {#sec4}
====================

General Information {#sec4.1}
-------------------

All reactions were performed under an argon atmosphere with oven (80 °C) or flame-dried glassware with septum seal. Tetrahydrofuran (THF) was distilled from sodium benzophenone under argon atmosphere immediately prior to use. Anhydrous toluene and dichloromethane were purchased from commercial sources. Reaction temperatures are reported as the temperature of the bath surrounding the reaction vessel. Analytical thin-layer chromatography (TLC) was performed on TLC Silica gel 60 F254. Visualization was accomplished with shortwave UV light, anisaldehyde, or KMnO~4~ staining solutions followed by heating. Chromatography was performed on silica gel (100--200 mesh) by standard techniques, and elution with solvents as indicated. ^1^H and ^13^C NMR spectra were recorded on Bruker AV 200, 400, and 500 in solvents as indicated. Chemical shifts (δ) are given in ppm. The residual solvent signals were used as references and the chemical shifts converted to the TMS scale (CDCl~3~: δ H = 7.27 ppm, δ C = 77.16 ppm), the following abbreviations were used: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; dd, doublet of doublet; td, triplet of doublet; and br, broad. HRMS data were recorded on a Thermo Scientific Q-Exactive, Accela 1250 pump. Experimental procedures for all new compounds and known compounds without published experimental procedures are described below. Compounds that are not presented in the main text (manuscript) are numbered starting from **S1**.

### 5-Methylenefuran-2(5*H*)-one (**11**) {#sec4.1.1}

To a solution of 2-methylfuran (**13**) (1 g, 12.18 mmol) in *t*-BuOH (36 mL) and H~2~O (6 mL) was added monobasic sodium phosphate monohydrate (2.1 g, 18.27 mmol) followed by sodium chlorite (3.3 g, 36.54 mmol) at 0 °C and allowed it to reach room temperature (rt) slowly. (**Caution:** After a brief initiation period of 1--2 min, the reaction mixture turned into a bright yellow/orange color and began to be exothermic, hence to be allowed to reach rt very slowly in 2--3 h). The reaction mixture was then transferred to a separatory funnel, and the aqueous layer and salts were drained. The *t*-BuOH layer was then collected, concentrated under reduced pressure to afford 5-hydroxy-5-methylfuran-2(5*H*)-one (**16**) TLC: *R*~f~ = 0.65 (SiO~2~, 10% CH~2~Cl~2~/MeOH); the crude product is subjected to next step without further purification. A suspension of crude 5-hydroxy-5-methylfuran-2(5*H*)-one (**16**) and P~2~O~5~ (10.29 g, 36.27 mmol) in benzene (30 mL) was refluxed for 5 h. The mixture was filtered through Celite, and the residue was washed with benzene (2 × 20 mL). The organic layer was concentrated under vacuo and the obtained crude product was purified by silica gel column chromatography (SiO~2~, 8% EtOAc/hexanes) afforded 5-methylenefuran-2(5*H*)-one (**11**) (0.82 g, 71% for two steps) TLC: *R*~f~ = 0.8 (SiO~2~, 70% EtOAc/hexanes); ^1^H NMR (CDCl~3~, 500 MHz): δ 7.41 (d, *J* = 5.7 Hz, 1H), 7.36 (benzene), 6.29--6.25 (m, 1H), 5.25 (t, *J* = 2.3 Hz, 1H), 4.93 (d, *J* = 2.7 Hz, 1H); ^13^C NMR (CDCl~3~, 126 MHz): δ 169.8, 154.9, 143.4, 128.3 (benzene), 121.7, 98.2.

### Diels--Alder Reaction between **11** and (*R*)-(−)-α-Phellandrene (**12**): Synthesis of **10a** and **10b** {#sec4.1.2}

A mixture of 5-methylenefuran-2(5*H*)-one (**11**) (0.4 g, 4.16 mmol) and (*R*)-(−)-α-phellandrene (∼80%) (**12**) (1.87 g, 13.72 mmol) in 2 mL toluene was refluxed for 12 h. After complete consumption of **11**, the solvent was removed under reduced pressure. The residue was carefully purified by silica gel column chromatography (SiO~2~, 2% EtOAc/hexanes) to afford the *endo*-(**10a**) (0.34 g, 35%) and *exo*-(**11a**) (0.34 g, 35%) isomers, along with trace amount of inseparable regio-isomer TLC: *R*~f~ = 0.3 and 0.2 (SiO~2~, 10% EtOAc/hexanes).

#### (1*R*,2*R*,4*R*,7*R*)-7-Isopropyl-5-methyl-5′*H*-spiro\[bicyclo\[2.2.2\]octane-2,2′-furan\]-5-en-5′-one (**10a**) {#sec4.1.2.1}

^1^H NMR (CDCl~3~, 500 MHz): δ 7.18 (d, *J* = 5.7 Hz, 1H), 5.85 (d, *J* = 5.3 Hz, 1H), 5.62 (d, *J* = 6.5 Hz, 1H), 2.46--2.42 (m, 1H), 2.37 (dd, *J* = 6.5, 1.5 Hz, 1H), 2.01--1.94 (m, 1H), 1.87--1.82 (m, 1H), 1.78 (d, *J* = 1.1 Hz, 3H), 1.71--1.6 (m, 2H), 1.14--1.05 (m, 1H), 1.02--0.95 (m, 1H), 0.78 (d, *J* = 6.9 Hz, 3H), 0.76 (d, *J* = 6.9 Hz, 3H); ^13^C NMR (CDCl~3~, 126 MHz): δ 173.2, 162.2, 145.4, 120.4, 118.2, 92.3, 43.3, 39.7, 36.3, 33.6, 32.8, 31.1, 20.9, 20.2, 19.9; IR (CHCl~3~, cm^--1^): ν 2957, 2927, 2856, 2361, 2342, 1749; HRMS (ESI) *m*/*z*: calcd for C~15~H~20~O~2~Na \[M + Na\]^+^, 255.1356; found, 255.1356.

#### (1*S*,2*R*,4*R*,8*R*)-8-Isopropyl-6-methyl-5′*H*-spiro\[bicyclo\[2.2.2\]octane-2,2′-furan\]-5-en-5′-one (**10b**) {#sec4.1.2.2}

^1^H NMR (CDCl~3~, 400 MHz): δ 7.58 (d, *J* = 5.5 Hz, 1H), 6.01 (d, *J* = 5.5 Hz, 1H), 5.78 (d, *J* = 5.5 Hz, 1H), 2.55--2.51 (m, 1H), 2.51--2.46 (m, 1H), 1.84 (s, 3H), 1.82--1.76 (m, 1H), 1.72--1.69 (m, 1H), 1.68--1.64 (m, 1H), 1.40--1.32 (m, 1H), 1.24--1.15 (m, 1H), 1.05--0.97 (m, 1H), 0.84 (d, *J* = 6.7 Hz, 3H), 0.82 (d, *J* = 6.7 Hz, 3H); ^13^C NMR (CDCl~3~, 101 MHz): δ 172.6, 159.9, 143.2, 121.7, 120.3, 93.3, 43.5, 41.8, 36.9, 35.9, 32.8, 31.0, 21.0, 20.5, 20.0; IR (CHCl~3~, cm^--1^): ν 2962, 2930, 2856, 2360, 2340, 1744; HRMS (ESI) *m*/*z*: calcd for C~15~H~20~O~2~Na \[M + Na\]^+^, 255.1356; found, 255.1355.

### (1*R*,2*S*,4*R*,7*R*)-7-Isopropyl-5-methyl-3′,4′-dihydro-5′*H*-spiro\[bicyclo\[2.2.2\]octane-2,2′-furan\]-5-en-5′-one (**S1**) {#sec4.1.3}

A mixture of (1*R*,2*R*,4*R*,7*R*)-7-isopropyl-5-methyl-5′*H*-spiro\[bicyclo\[2.2.2\]octane-2,2′-furan\]-5-en-5′-one (**10a**) (0.41 g, 1.76 mmol) and magnesium turnings (0.42 g, 17.6 mmol, pre-dried in oven at 120 °C) in 6 mL of dry methanol, was refluxed for 6 h. The mixture was cooled to 5--10 °C, and ice-cold 2 N aqueous HCl was added carefully and diluted with EtOAc. The solution was stirred for 15 min and filtered through sintered funnel to remove solid inorganic waste; organic layer was then separated, dried over anhydrous Na~2~SO~4~, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (SiO~2~, 4% EtOAc/hexanes) to afford the (1*R*,2*S*,4*R*,7*R*)-7-isopropyl-5-methyl-3′,4′-dihydro-5′*H*-spiro\[bicyclo\[2.2.2\]octane-2,2′-furan\]-5-en-5′-one (**S1**) (0.312 g, 76%) TLC: *R*~f~ = 0.55 (SiO~2~, 20% EtOAc/hexanes). ^1^H NMR (CDCl~3~, 400 MHz): δ 5.63 (d, *J* = 6.7 Hz, 1H), 2.59--2.47 (m, 3H), 2.40--2.33 (m, 1H), 2.14--2.03 (m, 1H), 1.93--1.79 (m, 4H), 1.77 (s, 3H), 1.57 (dt, *J* = 13.4, 3.0 Hz, 1H), 1.17--1.06 (m, 1H), 1--0.92 (m, 1H), 0.84 (d, *J* = 6.7 Hz, 3H), 0.80 (d, *J* = 6.7 Hz, 3H); ^13^C NMR (CDCl~3~, 101 MHz): δ 177.2, 145.3, 120.5, 90.2, 43.6, 40.2, 39.0, 37.0, 36.7, 32.8, 31.2, 28.8, 21.0, 20.3, 19.8; HRMS (ESI) *m*/*z*: calcd for C~15~H~22~O~2~Na \[M + Na\]^+^, 257.1512; found, 257.1511.

### (1*R*,2*R*,4*R*,7*R*)-7-Isopropyl-5-methyl-4′-(phenylselanyl)-3′,4′-dihydro-5′*H*-spiro\[bicyclo\[2.2.2\]octane-2,2′-furan\]-5-en-5′-one (**18**) {#sec4.1.4}

To a flame-dried (50 mL) two-neck round-bottom flask, anhydrous THF (10 mL) was added under argon atmosphere, and the mixture was cooled to 0 °C; to this, diisopropylamine (0.13 g, 1.29 mmol) followed by *n*-butyllithium (1.6 M in hexanes, 0.8 mL, 1.29 mmol) was added dropwise at 0 °C and stirred for 45 min at 0 °C to generate LDA. To this LDA solution was added (1*R*,2*S*,4*R*,7*R*)-7-isopropyl-5-methyl-3′,4′-dihydro-5′*H*-spiro\[bicyclo\[2.2.2\]octane-2,2′-furan\]-5-en-5′-one (**S1**) (0.1 g, 0.43 mmol) in THF (2 mL), and the reaction mixture was stirred at −78 °C for 30 min, and then phenyl selenyl chloride (0.09 g, 0.47 mmol) was added dropwise. The resulting mixture was stirred at −78 °C for 1 h and warmed to 25 °C and stirred overnight. The reaction was quenched with saturated aqueous NH~4~Cl solution and extracted with EtOAc (3 × 10 mL); combined organic layers were dried over anhydrous Na~2~SO~4~, concentrated under reduced pressure. The residue was purified by silica gel column chromatography (SiO~2~, 2% EtOAc/hexanes) to afford two separable diastereomers \[0.043 g, 35% less polar diastereomer **18**, TLC: *R*~f~ = 0.8 (SiO~2~, 10% EtOAc/hexanes)\] and \[0.046 g, 37% more polar diastereomer, **18a**, TLC: *R*~f~ = 0.7 (SiO~2~, 10% EtOAc/hexanes)\] of (1*R*,2*R*,4*R*,7*R*)-7-isopropyl-5-methyl-4′-(phenylselanyl)-3′,4′-dihydro-5′*H*-spiro\[bicyclo\[2.2.2\]octane-2,2′-furan\]-5-en-5′-one. Compound **18**: ^1^H NMR (CDCl~3~, 200 MHz): δ 7.72--7.60 (m, 2H), 7.41--7.28 (m, 3H), 5.59 (d, *J* = 6.6 Hz, 1H), 4.04 (dd, *J* = 9.0, 7.9 Hz, 1H), 2.57--2.45 (m, 1H), 2.36--2.30 (m, 1H), 2.05--1.8 (m, 3H), 1.75 (d, *J* = 1.6 Hz, 3H), 1.66--1.59 (m, 2H), 1.46 (dt, *J* = 13.8, 3.03 Hz, 1H), 1.14--1.04 (m, 1H), 0.98--0.88 (m, 1H), 0.82 (d, *J* = 6.57 Hz, 3H), 0.78 (d, *J* = 6.57 Hz, 3H). HRMS (ESI) *m*/*z*: calcd for C~21~H~27~O~2~Se \[M + H\]^+^, 391.1176; found, 391.1158. Compound **18a**: ^1^H NMR (CDCl~3~, 200 MHz): δ 7.72--7.62 (m, 2H), 7.39--7.29 (m, 3H), 5.57 (d, *J* = 6.6 Hz, 1H), 4.02 (dd, *J* = 9.1, 7.8 Hz, 1H), 2.56 (dd, *J* = 6.7, 1.5 Hz, 1H), 2.38--2.29 (m, 2H), 1.95--1.81 (m, 2H), 1.75 (d, *J* = 1.5 Hz, 3H), 1.68--1.58 (m, 3H), 1.16--1.04 (m, 1H), 0.97--0.9 (m, 1H), 0.83 (d, *J* = 6.57 Hz, 3H), 0.78 (d, *J* = 6.57 Hz, 3H). HRMS (ESI) *m*/*z*: calcd for C~21~H~27~O~2~Se \[M + H\]^+^, 391.1176; found, 391.1164.

### 3-(Phenylselanyl)dihydrofuran-2(3*H*)-one (**19**) {#sec4.1.5}

3-(Phenylselanyl)dihydrofuran-2(3*H*)-one (**19**) was prepared using the reported procedure. ^1^H NMR (CDCl~3~, 400 MHz): δ 7.68 (d, *J* = 7.3 Hz, 2H), 7.42--7.29 (m, 3H), 4.26 (td, *J* = 9.1, 4.3 Hz, 1H), 4.12 (q, *J* = 8.0 Hz, 1H), 3.93 (dd, *J* = 7.9, 4.3 Hz, 1H), 2.79--2.64 (m, 1H), 2.35--2.22 (m, 1H); ^13^C NMR (CDCl~3~, 101 MHz): δ 176.2, 135.9, 129.4, 129.2, 126.6, 67.0, 35.9, 30.6. HRMS (ESI) *m*/*z*: calcd for C~10~H~11~O~2~Se \[M + H\]^+^, 242.9925; found, 242.9923.

### 3-(1-Hydroxydodecyl)furan-2(5*H*)-one (**21**) {#sec4.1.6}

To a solution of the 3-(phenylselanyl)dihydrofuran-2(3*H*)-one (**19**) (1.0 g, 4.15 mmol) in THF (15 mL) was added LHMDS solution (4.57 mL, 1.0 M in THF, 4.57 mmol) dropwise at −78 °C. After the reaction mixture was stirred for 1 h, 1-dodecanal (0.99 g, 5.4 mmol) in THF (5 mL) was added. After 20 min of stirring at −78 °C, the reaction was quenched by the addition of a saturated NH~4~Cl solution (15 mL). The aqueous layer was extracted with diethyl ether (3 × 15 mL). The combined organic fractions were washed with brine, dried over Na~2~SO~4~, and concentrated under reduced pressure to afford the crude aldol product, which was used directly for oxidative elimination of phenyl selenenic acid without further purification. To a solution of crude aldol product obtained above in THF/EtOAc (1:1 v/v, 25 mL) were sequentially added NaHCO~3~ (3.14 g, 40.6 mmol) and hydrogen peroxide (30 wt %, 1.5 mL). After 10 min of stirring at rt, the reaction was quenched by the addition of a saturated Na~2~S~2~O~3~ solution (25 mL). The organic layer was collected, and the aqueous layer was extracted with EtOAc (3 × 25 mL). The combined organic fractions were washed with brine, dried over Na~2~SO~4~, and concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (SiO~2~, 40% EtOAc/hexanes) to give 3-(1-hydroxydodecyl)furan-2(5*H*)-one (**21**) (0.89 g, 81%) TLC: *R*~f~ = 0.2 (SiO~2~, 30% EtOAc/hexanes); ^1^H NMR (CDCl~3~, 500 MHz): δ 7.31 (q, *J* = 1.6 Hz, 1H), 4.83 (t, *J* = 1.7 Hz, 2H), 4.53--4.47 (m, 1H), 2.68 (br s, 1H), 1.83--1.63 (m, 2H), 1.51--1.41 (m, 1H), 1.37--1.22 (m, 17H), 0.88 (t, *J* = 7.0 Hz, 3H); ^13^C NMR (CDCl~3~, 126 MHz): δ 173.2, 144.7, 136.6, 70.4, 67.2, 35.5, 31.9, 29.61, 29.57, 29.54, 29.37, 29.3, 25.3, 22.7, 14.1; IR (CHCl~3~, cm^--1^): ν 2927, 2856, 2361, 2341, 1751; HRMS (ESI) *m*/*z*: calcd for C~16~H~28~O~3~Na \[M + Na\]^+^, 291.1931; found, 291.1929.

### 3-(1-Hydroxydodecyl)-5-methylenefuran-2(5H)-one (**14a**) {#sec4.1.7}

To a flame-dried (50 mL) two-neck round-bottom flask, anhydrous THF (5 mL) was added under argon atmosphere, and the mixture was cooled to 0 °C; to this, di-isopropylamine (0.1 mL, 0.74 mmol) followed by *n*-butyllithium (1.6 M in hexanes, 0.35 mL, 0.56 mmol) was added dropwise at 0 °C and stirred for 30 min at 0 °C to generate LDA solution. The solution was then cooled to −78 °C and subsequently treated with 3-(1-hydroxydodecyl)furan-2(5*H*)-one (**21**) (0.1 g, 0.37 mmol), dissolved in dry THF (2 mL). Stirring was continued for 1 h followed by the addition of Eschenmoser's salt (0.47 g, 2.59 mmol). The reaction mixture was stirred for 1 h and then allowed to warm to rt and stirred for 15 h. The reaction mixture was poured into saturated ammonium chloride solution (5 mL) and extracted with EtOAc (3 × 10 mL). The organic phase extracted was washed with water and brine and dried over anhydrous sodium sulphate, filtered, and the solvent was removed under reduced pressure. The crude product was purified by silica gel column chromatography (SiO~2~, 9% EtOAc/hexanes). Elimination of the amine occurs spontaneously on the silica gel to give 3-(1-hydroxydodecyl)-5-methylenefuran-2(5*H*)-one (**14a**) (0.052 g, 52%) TLC: *R*~f~ = 0.6 (SiO~2~, 30% EtOAc/hexanes); ^1^H NMR (CDCl~3~, 400 MHz): δ 7.22 (s, 1H), 5.20 (s, 1H), 4.89 (s, 1H), 4.64--4.54 (m, 1H), 2.50 (br s, 1H), 1.86--1.76 (m, 1H), 1.75--1.66 (m, 1H), 1.44--1.21 (m, 18H), 0.88 (t, *J* = 6.1 Hz, 3H); ^13^C NMR (CDCl~3~, 101 MHz): δ 169.2, 153.6, 138.3, 136.3, 97.6, 66.9, 35.7, 31.9, 29.61, 29.55, 29.51, 29.3, 25.2, 22.7, 14.1; IR (CHCl~3~, cm^--1^): ν 2927, 2855, 2362, 2344, 1769; HRMS (ESI) *m*/*z*: calcd for C~17~H~28~O~3~Na \[M + Na\]^+^, 303.1936; found, 303.1894.

### Diels--Alder Reaction between Dienophile **14a** and (*R*)-(−)-α-Phellandrene (**12**): Synthesis of **2** and **2a** {#sec4.1.8}

A mixture of 3-(1-hydroxydodecyl)-5-methylenefuran-2(5*H*)-one (**14a**) (0.3 g, 1.07 mmol) and (*R*)-(−)-α-phellandrene (**12**) (∼80%, 0.65 g, 4.82 mmol) in 1.5 mL toluene was refluxed for 20 h. After complete consumption of the dienophile **14a**, the solvent was removed under reduced pressure. The residue was carefully purified by silica gel column chromatography (SiO~2~, 2% EtOAc/hexanes) to afford (+)-yaoshanenolide B (**2**) (0.175 g, 39%), TLC: *R*~f~ = 0.6 (SiO~2~, 20% EtOAc/hexanes) and its C1″-epimer (**2a**) (0.162 g, 36%), TLC: *R*~f~ = 0.65 (SiO~2~, 20% EtOAc/hexanes).

#### (1*R*,2*S*,4*R*,7*R*)-1″-((*S*)-1-Hydroxydodecyl)-7-isopropyl-5-methyl-5′*H*-spiro\[bicyclo\[2.2.2\]octane-2,2′-furan\]-5-en-5′-one \[(+)-Yaoshanenolide B, (**2**)\] {#sec4.1.8.1}

\[α\]~D~ +14.0 (*c* = 1.0, CHCl~3~); ^1^H NMR (CDCl~3~, 500 MHz): δ 6.94 (s, 1H), 5.66 (d, *J* = 6.5 Hz, 1H), 4.43--4.39 (m, 1H), 2.59 (br s, 1H, −OH), 2.48--2.44 (m, 1H), 2.4 (dd, *J* = 6.5, 1.5 Hz, 1H), 2.05--1.97 (m, 1H), 1.91--1.85 (m, 1H), 1.82 (d, *J* = 1.1 Hz, 3H), 1.77--1.66 (m, 3H), 1.48--1.44 (m, 1H), 1.32--1.23 (m, 18H), 1.16--1.11 (m, 1H), 1.05--1.01 (m, 1H), 0.89 (t, *J* = 6.5 Hz, 3H), 0.84 (d, *J* = 6.5 Hz, 3H), 0.82 (d, *J* = 6.5 Hz, 3H); ^13^C NMR (CDCl~3~, 126 MHz): δ 172.8, 154.3, 145.4, 132.9, 120.5, 90.7, 67.0, 43.4, 39.7, 36.3, 35.5, 33.8, 32.8, 31.9, 31.1, 29.63 (2C), 29.57, 29.53, 29.37, 29.34, 25.4, 22.7, 20.9, 20.2, 19.9, 14.1; IR (CHCl~3~, cm^--1^): ν 2928, 2856, 2360, 2341, 1743; HRMS (ESI) *m*/*z*: calcd for C~27~H~44~O~3~Na \[M + Na\]^+^, 439.3183; found, 439.3181.

#### (1*R*,2*S*,4*R*,7*R*)-1″-((*R*)-1-Hydroxydodecyl)-7-isopropyl-5-methyl-5′*H*-spiro\[bicyclo\[2.2.2\]octane-2,2′-furan\]-5-en-5′-one \[*epi*-(+)-Yaoshanenolide B, (**2a**)\] {#sec4.1.8.2}

\[α\]~D~ +36.0 (*c* = 1.0, CHCl~3~); ^1^H NMR (CDCl~3~, 500 MHz): δ 6.95 (d, *J* = 0.76 Hz, 1H), 5.67 (br d, *J* = 6.5 Hz, 1H), 4.47--4.43 (m, 1H), 2.51 (br s, 1H, −OH), 2.47--2.44 (m, 1H), 2.41 (dd, *J* = 6.5, 1.5 Hz, 1H), 2.04--1.98 (m, 1H), 1.91--1.85 (m, 1H), 1.82 (d, *J* = 1.1 Hz, 3H), 1.77--1.64 (m, 4H), 1.48--1.44 (m, 1H), 1.34--1.22 (m, 18H), 1.18--1.11 (m, 1H), 1.05--1.00 (m, 1H), 0.89 (t, *J* = 6.8 Hz, 3H), 0.84 (d, *J* = 6.8 Hz, 3H), 0.82 (d, *J* = 6.4 Hz, 3H); ^13^C NMR (125 MHz, CDCl~3~): δ 172.8, 154.2, 145.4, 133.0, 120.5, 90.7, 66.9, 43.3, 39.7, 36.3, 35.5, 33.8, 32.8, 31.9, 31.1, 29.62 (2C), 29.56, 29.53, 29.36, 29.33, 25.3, 22.7, 20.9, 20.2, 19.8, 14.1; IR (CHCl~3~, cm^--1^): ν 2928, 2856, 2360, 2341, 1743; HRMS (ESI) *m*/*z*: calcd for C~27~H~44~O~3~Na \[M + Na\]^+^, 439.3183; found, 439.3181.

#### (*S*)-MPA Esters of (+)-Yaoshanenolide B (**2**) and Its 1″-Epimer (**2a**) {#sec4.1.8.3}

The MPA-esters **23** and **23a** were prepared using the reported procedure.^[@ref6]^ Compound **2** or **2a** (0.010 g, 0.02 mmol) was dissolved in anhydrous CH~2~Cl~2~ at rt, and then DMAP (2 mg), DCC (0.01 g, 0.06 mmol), and (*S*)-MPA (0.009 g, 0.06 mmol) were added sequentially at rt. After completion of the reaction (2 h), the resulting mixture was absorbed on to the silica gel and purified by the column chromatography (SiO~2~, 2% EtOAc/hexanes), to afford **23** and **23a** in 65 and 68% yield, respectively.

### (*S*)-1-((1*R*,2*S*,4*R*,7*R*)-7-Isopropyl-5-methyl-5′-*oxo*-5′*H*-spiro\[bicyclo\[2.2.2\]octane-2,2′-furan\]-5-en-4′-yl)dodecyl (*S*)-2-Methoxy-2-phenylacetate (**23**) {#sec4.1.9}

^1^H NMR (CDCl~3~, 500 MHz): δ 7.46--7.43 (m, 2H), 7.36--7.33 (m, 3H), 5.94 (d, *J* = 1.1 Hz, 1H), 5.59--5.55 (m, 1H), 5.45 (d*, J* = 6.5 Hz, 1H), 4.81 (s, 1H), 3.43 (s, 3H), 2.37--2.32 (m, 1H), 2.14 (dd, *J* = 6.5,1.5 Hz, 1H), 1.93--1.87 (m, 2H), 1.82 (d, *J* = 1.5 Hz, 3H), 1.8--1.76 (m, 1H), 1.72--1.66 (m, 1H), 1.53 (dd, *J* = 13.7, 2.0 Hz, 1H), 1.34--1.2 (m, 19H), 1.09--1.03 (m, 1H), 0.97--0.93 (m, 1H), 0.89 (t, *J* = 6.8 Hz, 3H), 0.78 (d, *J* = 3.8 Hz, 3H), 0.77 (d, *J* = 63.8 Hz, 3H); ^13^C NMR (CDCl~3~, 126 MHz): δ 170.9, 169.3, 154.7, 145.0, 136.3, 130.0, 128.8, 128.5, 127.3, 120.2, 90.1, 82.1, 69.5, 57.3, 43.2, 39.7, 36.2, 33.6, 32.8, 32.7, 31.9, 30.8, 29.7, 29.6, 29.5, 29.4, 29.3, 29.1, 25.1, 22.7, 20.9, 20.2, 20.1, 14.1; IR (CHCl~3~, cm^--1^): ν 2928, 2856, 2361, 2341, 1750; HRMS (ESI) *m*/*z*: calcd for C~36~H~52~O~5~Na \[M + Na\]^+^, 587.3707; found, 587.3709.

### (*R*)-1-((1*R*,2*S*,4*R*,7*R*)-7-Isopropyl-5-methyl-5′-*oxo*-5′*H*-spiro\[bicyclo\[2.2.2\]octane-2,2′-furan\]-5-en-4′-yl)dodecyl (*S*)-2-Methoxy-2-phenylacetate (**23a**) {#sec4.1.10}

^1^H NMR (CDCl~3~, 500 MHz): δ 7.49--7.46 (m, 2H), 7.39--7.34 (m, 3H), 6.75 (s, 1H), 5.58--5.54 (m, 1H), 5.50 (d, *J* = 6.5 Hz, 1H), 4.83 (s, 1H), 3.44 (s, 3H), 2.44--2.41 (m, 1H), 2.29 (dd, *J* = 7.0, 1.5 Hz, 1H), 2.0--1.94 (m, 1H), 1.88--1.84 (m, 1H), 1.82 (d, *J* = 1.1 Hz, 3H), 1.80--1.64 (m, 4H), 1.32--1.23 (m, 20H), 0.90 (t, *J* = 6.5 Hz, 3H), 0.81 (d, *J* = 7.0 Hz, 3H), 0.78 (d, *J* = 7.0 Hz, 3H); ^13^C NMR (125 MHz, CDCl~3~): 170.9, 169.9, 155.7, 145.2, 136.2, 129.8, 128.8, 128.6, 127.1, 120.5, 90.3, 82.6, 69.5, 57.4, 43.1, 39.6, 36.2, 33.8, 32.8, 32.6, 31.9, 31.1, 29.7, 29.63, 29.4, 29.3, 28.9, 24.6, 22.7, 20.9, 20.2, 19.9, 14.1; IR (CHCl~3~, cm^--1^): ν 2928, 2856, 2361, 2341, 1749; HRMS (ESI) *m*/*z*: calcd for C~36~H~52~O~5~Na \[M + Na\]^+^, 587.3707; found, 587.3710.

### 3-(1-Hydroxytetradecyl)furan-2(5*H*)-one (**22**) {#sec4.1.11}

To the lactone **19** (2.0 g, 8.29 mmol) in anhydrous THF (30 mL) was added LHMDS solution (9.12 mL, 1.0 M in THF, 9.12 mmol) dropwise at −78 °C under argon atmosphere, and then the mixture was continuously stirred for 1 h. Then, 1-tetradecanal^[@ref14]^ (2.11 g, 9.95 mmol) in anhydrous THF (10 mL) was added dropwise. After 30 min of stirring at −78 °C, the reaction was quenched by the addition of a saturated aqueous NH~4~Cl solution (20 mL). Then, extracted with diethyl ether (5 × 15 mL) and the combined organic layers were washed with brine solution, dried over anhydrous Na~2~SO~4~, and concentrated to give the crude aldol product, which was used directly for oxidative elimination step without further purification. To a solution of the above crude aldol product in THF and EtOAc (1:1 v/v, 50 mL) were sequentially added NaHCO~3~ (6.82 g, 81.2 mmol) and H~2~O~2~ (30 wt % in water, 3.2 mL). After 20 min of stirring at rt, the reaction mixture was quenched by the addition of saturated Na~2~S~2~O~3~ solution (25 mL). The organic layer was collected, and the aqueous layer was further extracted with EtOAc (3 × 25 mL). The combined organic layers were washed with brine, dried over Na~2~SO~4~, and concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (SiO~2~, 40% EtOAc/hexanes) afforded 3-(1-hydroxytetradecyl)furan-2(5*H*)-one (**22**) (2.1 g, 78%) TLC: *R*~f~ = 0.2 (SiO~2~, 30% EtOAc/hexanes); ^1^H NMR (CDCl~3~, 500 MHz): δ 7.34--7.32 (m, 1H), 4.84 (t, *J* = 1.5 Hz, 2H), 4.54--4.49 (m, 1H), 2.57 (br s, 1H), 1.83--1.65 (m, 2H), 1.35--1.22 (m, 22H), 0.88 (t, *J* = 7.0 Hz, 3H); ^13^C NMR (CDCl~3~, 126 MHz): δ 173.1, 144.6, 136.6, 70.4, 67.2, 35.5, 31.9, 29.6, 29.5, 29.5, 29.3, 25.3, 22.7, 14.1; IR (CHCl~3~, cm^--1^): ν 2928, 2855, 2361, 2341, 1750; HRMS (ESI) *m*/*z*: calcd for C~18~H~32~O~3~Na \[M + Na\]^+^, 319.2244; found, 319.2239.

### 3-(1-Hydroxytetradecyl)-5-methylenefuran-2(5*H*)-one (**14b**) {#sec4.1.12}

To a flame-dried (100 mL) two-neck round-bottom flask, anhydrous THF (40 mL) was added under argon atmosphere, and the mixture was cooled to 0 °C; to this, diisopropylamine (0.77 mL, 5.4 mmol) followed by *n*-butyllithium (1.6 M in hexanes, 2.53 mL, 4.05 mmol) was added dropwise at 0 °C and stirred for 30 min at 0 °C to generate LDA solution. The solution was then cooled to −78 °C and subsequently treated with 3-(1-hydroxytetradecyl)furan-2(5*H*)-one (**22**) (0.8 g, 2.7 mmol), dissolved in dry THF (5 mL). Stirring was continued for 1 h followed by addition of Eschenmoser's salt (3.49 g, 18.9 mmol). The reaction mixture was stirred for 1 h and then allowed to warm to rt and stirred for 15 h. The reaction mixture was poured into saturated ammonium chloride solution (5 mL) and extracted with ethyl acetate (3 × 10 mL). The organic phase extracted was washed with water and brine and dried over anhydrous sodium sulphate, filtered, and the solvent was removed under reduced pressure. The crude product was purified by silica gel column chromatography (SiO~2~, 9% EtOAc/hexanes) (SiO~2~, 9% EtOAc/hexanes). Elimination of the amine occurs spontaneously on the silica gel to afford 3-(1-hydroxytetradecyl)-5-methylenefuran-2(5*H*)-one (**14b**) (0.41 g, 49%) TLC: *R*~f~ = 0.6 (SiO~2~, 30% EtOAc/hexanes); ^1^H NMR (CDCl~3~, 500 MHz): δ 7.21 (s, 1H), 5.21 (d, *J* = 2.7 Hz, 1H), 4.89 (d, *J* = 2.7 Hz, 1H), 4.60 (dd, *J* = 6.9, 4.6 Hz, 1H), 2.45--2.36 (m, 1H), 1.86--1.77 (m, 1H), 1.74--1.66 (m, 1H), 1.36--1.23 (m, 22H), 0.88 (t, *J* = 6.9 Hz, 3H); ^13^C NMR (CDCl~3~, 126 MHz): δ 169.2, 153.7, 138.3, 136.3, 97.5, 67.0, 35.7, 31.9, 29.7, 29.6, 29.5, 29.4, 25.2, 22.7, 14.1; IR (CHCl~3~, cm^--1^): ν 2927, 2854, 2361, 2341, 1765; HRMS (ESI) *m*/*z*: calcd for C~19~H~32~O~3~Na \[M + Na\]^+^, 331.2244; found, 331.2242.

### Diels--Alder Reaction between Dienophile (**14b**) and (*R*)-(−)-α-Phellandrene (**12**) {#sec4.1.13}

A mixture of 3-(1-hydroxytetradecyl)-5-methylenefuran-2(5*H*)-one (**14b**) (0.4 g, 1.3 mmol) and (*R*)-(−)-α-phellandrene (**12**) (∼80%, 0.88 g, 6.5 mmol) in 2 mL toluene was refluxed for 20 h. After complete consumption of butenolide (**14b**), the solvent was removed under reduced pressure. The residue was carefully purified by silica gel column chromatography (SiO~2~, 2% EtOAc/hexanes) to afford (+)-yaoshanenolide A (**1**) (0.213 g, 37%), TLC: *R*~f~ = 0.55 (SiO~2~, 20% EtOAc/hexanes); and C-1″-*epi*-(+)-yaoshanenolide A (**1a**) (0.202 g, 35%). TLC: *R*~f~ = 0.60 (SiO~2~, 20% EtOAc/hexanes).

### (1*R*,2*S*,4*R*,7*R*)-41″-((*S*)-1-Hydroxytetradecyl)-7-isopropyl-5-methyl-5′*H*-spiro\[bicyclo\[2.2.2\]octane-2,2′-furan\]-5-en-5′-one \[(+)-yaoshanenolide-A (**1**)\] {#sec4.1.14}

\[α\]~D~ +16.9 (*c* = 1.0, CHCl~3~); ^1^H NMR (CDCl~3~, 400 MHz): δ 6.94 (s, 1H), 5.67 (d, *J* = 6.1 Hz, 1H), 4.48--4.39 (m, 1H), 2.60--2.55 (m, 1H), 2.49--2.44 (m, 1H), 2.41 (dd, *J* = 6.7, 1.2 Hz, 1H), 2.08--1.96 (m, 1H), 1.93--1.86 (m, 1H), 1.83 (s, 3H), 1.74--1.66 (m, 4H), 1.30--1.23 (m, 22 H), 1.16--1.11 (m, 1H), 1.06--1.0 (m, 1H), 0.89 (t, *J* = 6.7 Hz, 3H), 0.84 (d, *J* = 7.32 Hz, 3H), 0.82 (d, *J* = 7.32 Hz, 3H); ^13^C NMR (CDCl~3~, 101 MHz): δ 172.9, 154.2, 145.4, 132.9, 120.5, 90.7, 67.1, 43.4, 39.7, 36.4, 35.5, 33.8, 32.9, 31.9, 31.1, 29.67 (2C), 29.65 (2C), 29.58, 29.54, 29.37 (2C), 25.4, 22.7, 20.9, 20.2, 19.9, 14.1; HRMS (ESI) *m*/*z*: calcd for C~29~H~48~O~3~Na \[M + Na\]^+^, 467.3496; found, 467.3497.

### (1*R*,2*S*,4*R*,7*R*)-1″-((*R*)-1-Hydroxytetradecyl)-7-isopropyl-5-methyl-5′*H*-spiro\[bicyclo\[2.2.2\]octane-2,2′-furan\]-5-en-5′-one \[C-1″-*epi*-(+)-Yaoshanenolide-A (**1a**)\] {#sec4.1.15}

\[α\]~D~ +34.0 (*c* = 2.0, CHCl~3~); ^1^H NMR (CDCl~3~, 400 MHz): δ 6.95 (s, 1H), 5.66 (d, *J* = 6.1 Hz, 1H), 4.49--4.4 (m, 1H), 2.56--2.51 (m, 1H), 2.49--2.43 (m, 1H), 2.41 (dd, *J* = 6.71, 1.22 Hz, 1H), 2.05--1.96 (m, 1H), 1.93--1.86 (m, 1H), 1.82 (s, 3H), 1.76--1.66 (m, 4H), 1.26 (m, 22H), 1.15--1.11 (m, 1H), 1.06--1.0 (m, 1H), 0.88 (t, *J* = 6.1 Hz, 3H), 0.83 (d, *J* = 6.71 Hz, 3H), 0.81 (d, *J* = 6.71 Hz, 3H); ^13^C NMR (101 MHz, CDCl~3~): δ 172.8, 154.2, 145.4, 133.0, 120.6, 90.7, 67.0, 43.4, 39.7, 36.4, 35.5, 33.8, 32.9, 32.0, 31.9, 31.2, 29.86, 29.79, 29.69, 29.65, 29.58, 29.54, 29.37, 25.3, 22.7, 20.9, 20.2, 19.9, 14.1; HRMS (ESI) *m*/*z*: calcd for C~29~H~48~O~3~Na \[M + Na\]^+^, 467.3496; found, 467.3494.

### (*S*)-MPA Esters of (+)-Yaoshanenolide A (**1**) and Its C1″-Epimer (**1a**) {#sec4.1.16}

The MPA-esters **24** and **24a** were prepared using the reported procedure.^[@ref6]^ Compound **1** or **1a** (0.02 g, 0.04 mmol) was dissolved in anhydrous CH~2~Cl~2~ at rt, and then DMAP (3 mg), DCC (0.0.024 g, 0.12 mmol), and (*S*)-MPA (0.019 g, 0.12 mmol) were added sequentially at rt. After completion of the reaction (2 h), the resulting mixture was absorbed on to the silica gel and purified by the column chromatography (SiO~2~, 2% EtOAc/hexanes), to afford **24** and **24a** in 62 and 66% yield, respectively.

### (*S*)-1-((1*R*,2*S*,4*R*,7*R*)-7-Isopropyl-5-methyl-5′-*oxo*-5′*H*-spiro\[bicyclo\[2.2.2\]octane-2,2′-furan\]-5-en-4′-yl)tetradecyl (*S*)-2-Methoxy-2-phenylacetate (**24**) {#sec4.1.17}

^1^H NMR (CDCl~3~, 400 MHz): δ 7.47--7.42 (m, 2H), 7.38--7.32 (m, 3H), 5.92 (s, 1H), 5.6--5.54 (m, 1H), 5.45 (d, *J* = 6.1 Hz, 1H), 4.81 (s, 1H), 3.43 (s, 3H), 2.37--2.31 (m, 1H), 2.14 (d, *J* = 6.1 Hz, 1H), 1.92--1.86 (m, 1H), 1.81 (s, 3H), 1.76--1.59 (m, 3H), 1.54--1.48 (m, 1H), 1.3--1.22 (m, 22H), 1.14--1.1 (m, 3H), 0.89 (t, *J* = 5.5 Hz, 3H), 0.78 (d, *J* = 6.71 Hz, 3H), 0.77 (d, *J* = 6.71 Hz, 3H); ^13^C NMR (CDCl~3~, 101 MHz): δ 170.9, 169.3, 154.7, 145.0, 136.4, 130.0, 128.8, 128.6, 127.3, 120.3, 90.1, 82.1, 69.5, 57.3, 43.3, 39.7, 36.2, 33.7, 32.8, 32.8, 31.9, 30.8, 29.70 (2C), 29.68 (2C), 29.67 (2C), 29.56, 29.45, 29.37, 29.14, 25.1, 22.7, 20.9, 20.2, 20.1, 14.1; IR (CHCl~3~, cm^--1^): ν 2928, 2855, 2360, 2341, 1749; HRMS (ESI) *m*/*z*: calcd for C~38~H~56~O~5~Na \[M + Na\]^+^, 615.4020; found, 615.4012.

### (*R*)-1-((1*R*,2*S*,4*R*,7*R*)-7-Isopropyl-5-methyl-5′-*oxo*-5′*H*-spiro\[bicyclo\[2.2.2\]octane-2,2′-furan\]-5-en-4′-yl)tetradecyl (*S*)-2-Methoxy-2-phenylacetate (**24a**) {#sec4.1.18}

^1^H NMR (CDCl~3~, 400 MHz): δ 7.50--7.44 (m, 2H), 7.41--7.33 (m, 3H), 6.75 (s, 1H), 5.57--5.53 (m, 1H), 5.50 (d, *J* = 6.1 Hz, 1H), 4.82 (s, 1H), 3.44 (s, 3H), 2.46--2.39 (m, 1H), 2.29 (d, *J* = 6.7 Hz, 1H), 2.02--1.92 (m, 1H), 1.82 (s, 3H), 1.80--1.61 (m, 4H), 1.35--1.2 (m, 22H), 1.06--0.96 (m, 3H), 0.89 (t, *J* = 6.1 Hz, 3H), 0.81 (d, *J* = 6.71 Hz, 3H), 0.79 (d, *J* = 6.71 Hz, 3H); ^13^C NMR (101 MHz, CDCl~3~): 170.9, 169.9, 155.7, 145.2, 136.2, 129.9, 128.8, 128.6, 127.1, 120.6, 90.3, 82.7, 69.5, 57.4, 43.2, 39.6, 36.3, 33.8, 32.9, 32.6, 31.9, 31.1, 29.70 (2C), 29.66 (2C), 29.61 (2C), 29.45, 29.37, 29.34, 28.97, 24.7, 22.7, 20.9, 20.2, 19.9, 14.1; HRMS (ESI) *m*/*z*: calcd for C~38~H~56~O~5~Na \[M + Na\]^+^, 615.4020; found, 615.4020.

### 1-(5-Methylene-2-*oxo*-2,5-dihydrofuran-3-yl)dodecyl Acetate (**14a′**) {#sec4.1.19}

Acetic anhydride (0.07 g, 0.76 mmol) was added to an ice-cooled solution of 3-(1-hydroxydodecyl)-5-methylenefuran-2(5*H*)-one (**14a**) (0.1 g, 0.36 mmol) in pyridine (200 μL), and the mixture was stirred at rt for 30 min. Then, ethanol (0.5 mL) was added at rt and stirred for further 30 min. The reaction mixture was poured into cold 1 N aqueous hydrochloric acid and extracted with ethyl acetate (3 × 5 mL). The organic layers were combined, washed with water and brine, and dried over anhydrous Na~2~SO~4,~ filtered using sintered funnel and concentrated under vacuum. The crude product was purified by silica gel column chromatography (SiO~2~, 4% EtOAc/hexanes) to afford 1-(5-methylene-2-*oxo*-2,5-dihydrofuran-3-yl)dodecyl acetate (**14a′**) (0.045 g, 40%) TLC: *R*~f~ = 0.9 (SiO~2~, 30% EtOAc/hexanes); ^1^H NMR (CDCl~3~, 400 MHz): δ 7.17 (s, 1H), 5.68--5.62 (m, 1H), 5.20 (d, *J* = 2.4 Hz, 1H), 4.88 (d, *J* = 2.4 Hz, 1H), 2.11 (s, 3H), 1.93--1.78 (m, 2H), 1.28--1.21 (m, 18H), 0.87 (t, *J* = 6.7 Hz, 3H); ^13^C NMR (CDCl~3~, 101 MHz): δ 169.9, 167.8, 153.3, 137.5, 134.9, 97.8, 68.5, 32.9, 31.9, 29.6, 29.5, 29.4, 29.3, 29.2, 25.0, 22.7, 20.9, 14.1, 1.0.

### Diels--Alder Reaction among **14a** and (*R*)-α-(−)-Phellandrene {#sec4.1.20}

A mixture of 1-(5-methylene-2-*oxo*-2,5-dihydrofuran-3-yl)dodecyl acetate **14a′** (0.04 g, 0.12 mmol) and (*R*)-α-(−)-phellandrene (**12**, ∼85%) (0.07 g, 0.54 mmol) in 1 mL of toluene was refluxed for 20 h. After complete consumption of the dienophile **14a′**, the solvent was removed under reduced pressure. Purification using silica gel column chromatography (SiO~2~, 2% EtOAc/hexanes) afforded the mixture of compounds (two spots showed on TLC, which are the mixtures with epimers and exo/endo isomers). These two spots were subjected to acetate hydrolysis using Stratakis's reported method,^[@ref6]^ purified by preparative TLC fractionation, and subjected to ^1^H NMR analysis, and the obtained data were utilized to identify the endo/exo ratio of this work.
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